Chapter 6- Endocrine System Flashcards
What is vasopressin and desmopressin?
Antidiuretic hormone (ADH)
Which is more potent and has a longer duration of action: desmopressin or vasopressin?
Desmopressin
Which has a vasoconstrictor effect: desmopressin or vasopressin
Vasopressin
Vasopressin can be used to stop variceal bleeding in what?
Portal hypertension
Name two antidiuretic hormone antagonists
Demeclocycline
Tolvaptan
Rapid correct of hyponatraemia with tolvaptan can cause what
Osmotic demyelination leading to serious neurological events
The antidiuretic hormones vasopressin and desmopressin can cause what
Hyponatraemia
Name 5 mineralocorticoid side effects
Hypertension Sodium retention Water retention Potassium loss Calcium loss
Name 6 side effects from glucocorticoids
Diabetes Osteoporosis Avascular necrosis of femoral head Muscle wasting Peptic ulceration Psychiatric reactions
Children under 15 years should use what to inhale corticosteroids
Large volume spacer
Name two drugs used in cushings
Ketoconazole
Metyrapone
Name 3 rapid acting insulin analogues
Insulin aspart
Insulin glulisine
Insulin lispro
When soluble insulin is injected subcutaneously what’s its onset of action, peak action and duration of action?
Onset: 30-60mins
Peak: 1-4hrs
Duration: 9 hours
When soluble insulin is given intravenously what’s its half life and onset of action - as a result of this when is it used
Half life: few mins
Onset: instantaneous
Used: in medical emergencies e.g DKA & Peri-operatively
Onset and duration of action of the rapid acting insulins (aspart, glulisine,lispro)
Onset: 15 mins
Duration: 2-5hrs
Name an intermediate acting insulin and what’s its onset of action and duration
Isophane insulin
Onset: 1-2hrs
Duration: 11-24hrs
Name three long acting insulins
Insulin degludec (OD) Insulin detemir (BD) Insulin glargine (OD)
Metformin when given alone does not cause hypos- why?
Because it does not stimulate insulin secretion
Name 5 sulfonylureas and which one is most recommended for pregnancy?
Glibenclamide Gliclazide Glimepiride Glipizide Tolbutamide
Sulfonylureas can cause hypos but it is more associated with the long acting sulfonylureas such as ?
Glibenclamide
True or false: sulfonylureas can cause modest weight gain
True
Name two meglitinides and what’s their onset of action and duration like?
Nateglinide
Repaglinide
Rapid onset of action
Short duration of activity
Name a thiazolidinedione
Pioglitazone
The dipeptidylpeptidase-4 inhibitors (gliptins) are not associated with weight gain and cause hypos to a lesser extent than the sulfonylureas, name these drugs
Alogliptin Linagliptin Sitagliptin Saxagliptin Vildagliptin
Name three sodium glucose co-transporter 2 inhibitors
Canagliflozin
Dapagliflozin
Empagliflozin
Which class of oral diabetic medication is associated with DKA
Sodium glucose co-transporter 2 inhibitors
Name 4 glucagon- like peptide 1 receptor agonists
Albiglutide Dulaglutide Exenatide Liraglutide Lixisenatide
What’s another indication for metformin
Used as an insulin sensitising drug in women with polycystic ovary syndrome who are not planning pregnancy (unlicensed)
Normal HbA1c target for patient with diabetes
48 mmol/mol (6.5%) or lower
If someone is on an antidiabetic drug that causes hypos or two or more antidiabetic drugs, what’s their HbA1c target
53mmol/mol
When do you use glucagon-like peptide 1 receptor agonists
Triple therapy with metformin + sulfonylureas in patient with BMI 35+, or if <35 but have other conditions that would benefit from weight loss
When should you review glucagon-like peptide 1 receptor agonists
6 months after initiation- only continue if there’s a reduction of at least 11mmol/mol in HbA1c and a weight loss of at least 3% of initial body weight
True or false: ACEI can potentiate the hypoglycaemic effect of insulin and oral antidiabetic drugs
TRUE
MOA of acarbose
Inhibitor of alpha glucosidases, delays the digestion and absorption of starch and sucrose, it has small but significant effect in lowering blood glucose
Cautions with acarbose
May enhance hypoglycaemia effects of insulin and sulfonylureas (hypoglycaemic episodes must be treated with oral glucose but not sucrose)
MOA of metformin
Decreases gluconeogenesis and increases peripheral utilisation of glucose
True or false: metformin acts only in presence of endogenous insulin it is effective only if there are some residual functioning pancreatic islet cells
True dat
Metformin and pregnancy?
Metformin can be used for both pre-existing and gestational diabetes
Metformin- avoid if what renal impairment?
If eGFR < 30ml/min/1.73m^2
Potential signs of lactic acidosis with metformin
Dyspnoea Hypothermia Abdominal pain Muscle cramps Asthenia (weakness)
“DHAMA”
Side effects/ caution with DPP-4 inhibitors (gliptins)
Pancreatitis
Which DPP-4 inhibitor has reports of liver toxicity
Vildagliptin
How do the meglitinides work (nateglinide + repaglinide)
Stimulates insulin secretion
Mode of action of sodium glucose co-transporter 2 (SGLT2) inhibitors (canagliflozin, dapagliflozin, empagliflozin)
Reversible inhibits SGLT2 in the renal proximal convoluted tubule to reduce glucose reabsorbtion and increase urinary glucose excretion
Patients on canagliflozin and rifampicin - increase the SGLT2 dose to want?
300mg OD
MHRA warning with all SGLT2 inhibitors (canagliflozin, dapagliflozin, empagliflozin
Risk of DKA
In addition to risk of DKA, what other caution is there with canagliflozin
Increased risk of lower limb amputation (mainly toes)
The SGLT2 inhibitors have an increased risk of volume depletion - true or false?
True - therefore caution in hypotension, elderly, heart failure, and when your pissing out salt and glucose, water follows so loosing water = hypotension
MOA of sulfonylureas
Augment insulin secretion therefore effective only when there’s some residual pancreatic beta cell activity
Cautions for sulfonylureas
Weight gain
Elderly (hypos)
G6PD deficiency
Contraindication for glibenclamide
Acute porphyrias
True or false: the sulfonylurea ‘glibenclamide’ can be used in the second and third trimesters to treat gestational diabetes
True
Sulfonylureas should be avoided in porphyria- which two are thought to be safe?
Glimepiride
Glipizide
MOA of the thiazolidinedione ‘pioglitazone’
Reduces peripheral insulin resistance